Skip to main content
SpringerLink
Log in

Vitiligo and Immunodeficiencies

  • Chapter
Book cover Vitiligo

Core Messages

  • Combined or T-cell immunodeficiencies, inherited or acquired, are commonly associated with autoimmunity.

  • Vitiligo has been reported to be associated with cellular or combined immunodeficien-cies, suggesting a possible link to pathomech-anisms involved in common nonsegmental vitiligo.

  • Although there is some evidence that both cellular and humoral immunity can act together in vitiligo pathogenesis, the associations noted in this chapter suggest that cellular immunity is more implicated in disease causation or progression.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Abdallah M, Abdel-Nasr MB, Moussa MH et al (2003) Sequential immunohistochemical study of depigmenting and repigmenting minigrafts in vitiligo. Eur J Dermatol 13:548–552

    PubMed  Google Scholar 

  2. Antony FC, Marsden RA (2003) Vitiligo in association with human immunodefi ciency virus infection. J Eur Acad Dermatol Venereol 20:63–65

    Google Scholar 

  3. Berkowitz DM, Passaro E Jr, Isenberg JI (1977) Hypertrophic protein-losing gastropathy and vitiligo. Report of a second case. Am J Dig Dis 22:554–557

    Article  PubMed  CAS  Google Scholar 

  4. Brown KL, Bylund J, MacDonald KL et al (2008) ROS-defi cient monocytes have aberrant gene expression that correlates with inflammatory disorders of chronic granulomatous disease. Clin Immunol 129:90–102

    Article  PubMed  CAS  Google Scholar 

  5. CDC (1993) 1992 revised classifi cation system for HIV infection and expanded surveillance case defi nition for AIDS among adolescents and adults. MMWR 41(RR–17): 961–962

    Google Scholar 

  6. Cho M, Cohen PR, Duvic M (1995) Vitiligo and alopecia areata in patients with human immunodefi ciency virus infection. South Med J 88:489–491

    Article  PubMed  CAS  Google Scholar 

  7. Clark R, Kupper TS (2005) Old meets the new: the interaction between innate and adaptive immunity. J Invest Dermatol 125:629–637

    Article  PubMed  CAS  Google Scholar 

  8. Dejaco C, Duftner C, Grubeck-Loebenstein B, Schirmer M (2006) Imbalance of regulatory T cells in human autoimmune diseases. Immunology 117:289–300

    Article  PubMed  CAS  Google Scholar 

  9. Dhasmana DJ, Dheda K, Ravn P, Wilkinson RJ, Meintjes G (2008) Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy: patho-genesis, clinical manifestations and management. Drugs 68:191–208

    Article  PubMed  CAS  Google Scholar 

  10. Duvic M, Rapini R, Hoots WK et al (1987) Human immuno-defi ciency virus-associated vitiligo: expression of autoim-munity with immunodefi ciency?. J Am Acad Dermatol 17:656–662

    Article  PubMed  CAS  Google Scholar 

  11. El-Ghorr AA, Norval M (1997) Biological effects of narrowband (311 nm TL01) UVB irradiation: a review. J Photochem Photobiol B 38:99–106

    Article  PubMed  CAS  Google Scholar 

  12. French MA (2009) HIV/AIDS: immune reconstitution inflammatory syndrome: a reappraisal. Clin Infect Dis 48:101–107

    Article  PubMed  Google Scholar 

  13. García-Patos Briones V, Rodríguez Cano L, Capdevila Morell JA, Costells Rodellas A (1994) Vitiligo associated with the acquired immunodefi ciency syndrome. Med Clin (Barc) 103:358

    Google Scholar 

  14. Grandhe NP, Dogra S, Kumar B (2006) Spontaneous repigmentation of vitiligo in an untreated HIV-positive patient. J Eur Acad Dermatol Venereol 20:234–235

    Article  PubMed  CAS  Google Scholar 

  15. Knight AK, Cunningham-Randles C (2006) Inflammatory and autoimmune complications of common variable immune defi ciency. Autoimmun Rev 5:156–159

    Article  PubMed  CAS  Google Scholar 

  16. Jin Y, Mailloux CM, Gowan K et al (2007) NALP1 in viti-ligo-associated multiple autoimmune disease. N Eng J Med 356:1216–1225

    Article  CAS  Google Scholar 

  17. Kuzmanovska DB, Shahpazova EM, Kocova MJ et al (2001) Autoimmune thyroiditis and vitiligo in a child with minimal change nephrotic syndrome. Pediatr Nephrol 16:1137–1138

    Article  PubMed  CAS  Google Scholar 

  18. Lim A, Tan D, Price P et al (2007) Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretro-viral therapy. AIDS 21:1525–1534

    Article  PubMed  Google Scholar 

  19. Liston A, Enders A, Siggs OM (2008) Unravelling the association of partial T-cell immunodefi ciency and immune dys-regulation. Nat Rev Immunol 8:545–558

    Article  PubMed  CAS  Google Scholar 

  20. Mandelcorn-Monson RL, Shear NH, Yau E et al (2003) Cytotoxic T lymphocyte reactivity to gp100, MelanA/ MART-1, and tyrosinase, in HLA-A2-positive vitiligo patients. J Invest Dermatol 121:550–556

    Article  PubMed  CAS  Google Scholar 

  21. Milner JD, Fasth A, Etzioni A (2008) Autoimmunity in severe combined immunodefi ciency (SCID): lessons from patients and experimental models. J Clin Immunol S1: S29–S33

    Article  Google Scholar 

  22. Murdoch DM, Venter WDF, Van Rie A, Feldman C (2007) Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS Res Ther 4:9

    Article  PubMed  Google Scholar 

  23. Newman MD, Milgraum S (2008) Leukemia cutis masquerading as vitiligo. Cutis 81:163–165

    PubMed  Google Scholar 

  24. Niamba P, Traoré A, Taieb A (2007) Vitiligo sur peau noire associée au VIH et repigmentation lors du traitement antiret-roviral. Ann Dermatol Venereol 134:272–276

    Article  PubMed  CAS  Google Scholar 

  25. Onay H, Pehlivan M, Alper S et al (2007) Might there be a link between mannose binding lectin and vitiligo?. Eur J Dermatol 17:146–148

    PubMed  CAS  Google Scholar 

  26. Park MA, Li JT, Hagan JB et al (2008) Common variable immunodefi ciency: a new look at an old disease. Lancet 372:489–502

    Article  PubMed  Google Scholar 

  27. Ponsonby AL, Lucas RM, van der Mei IA (2005) UVR, vitamin D and three autoimmune diseases-multiple sclerosis, type 1 diabetes, rheumatoid arthritis. Photochem Photobiol 81:1267–1275

    Article  PubMed  CAS  Google Scholar 

  28. Tojo N, Yoshimura N, Yoshizawa M et al (1991) Vitiligo and chronic photosensitivity in human immunodefi ciency virus infection. Jpn J Med 3:255–259

    Article  Google Scholar 

  29. Van den Wijngaard R, Wankowicz-Kalinska A, Le Poole C et al (2000) Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes associated with the prominent presence of CLA+ T cells at the perilesional site. Lab Invest 80:1299–1309

    Article  PubMed  Google Scholar 

  30. Venneker GT, Westerhof W, de Vries IJ et al (1992) Molecular heterogeneity of the fourth component of complement (C4) and its genes in vitiligo. J Invest Dermatol 99:853–858

    Article  PubMed  CAS  Google Scholar 

  31. Westerhof W, d'Ischia M (2007) Vitiligo puzzle: the pieces fall in place. Pigment Cell Res 20:345–359

    PubMed  CAS  Google Scholar 

  32. Yamauchi PS, Nguyen NQ, Grimes PE (2002) Idiopathic CD4+ T-cell lymphocytopenia associated with vitiligo. J Am Acad Dermatol 46:779–782

    Article  PubMed  Google Scholar 

  33. Zandman-Goddard G, Shoenfeld Y (2002) HIV and autoim-munity. Autoimmunity Rev 1:329–337

    Article  CAS  Google Scholar 

  34. Zonios DI, Falloon J, Bennett JE, Shaw PA, Chaitt D, Baseler MW et al (2008) Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors. Blood 112:287–294

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de dermatologie, Hôspital St André, CHU de Bordeaux, France

    Khaled Ezzedine

  2. Department of Pathology, Hôpital Pellegrin, CHU de Bordeaux, France

    Sébastien Lepreux

  3. Service de Dermatologie De Dermatologie Pédiatrique, Centre de référence des maladies rares de la Peau Hôpital Saint-André, 1 rue Jean Burguet, Bordeaux, 33000, France

    Alain Taïeb

Authors
  1. Khaled Ezzedine
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sébastien Lepreux
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alain Taïeb
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Khaled Ezzedine .

Editor information

Editors and Affiliations

  1. Istituto Dermatologico San Gallicano, via Elio Chianesi 53, Roma, 00144, Italy

    Mauro Picardo

  2. Service de Dermatologie De Dermatologie Pédiatrique, Centre de référence des maladies rares de la Peau Hôpital Saint-André, 1 rue Jean Burguet, Bordeaux, 33000, France

    Alain Taïeb

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Ezzedine, K., Lepreux, S., Taïeb, A. (2010). Vitiligo and Immunodeficiencies. In: Picardo, M., Taïeb, A. (eds) Vitiligo. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69361-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-69361-1_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-69360-4

  • Online ISBN: 978-3-540-69361-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation